| Filed On | Filing |
|---|---|
| 24 Sep 2026 |
8-K: Other Events
CARDIFF LEXINGTON CORPORATION ANNOUNCES LETTER OF INTENT FOR PROPOSED ACQUISITION OF LEADING MUSCULOSKELETAL HEALTHCARE PLATFORM |
| 15 Sep 2026 |
Form 4: Staley Louis Jack Sr., Director
Granted 500,000 Stock Option |
| 15 Sep 2026 |
Form 4: Pennington Catherine B., Director
Granted 500,000 Stock Option |
| 15 Sep 2026 |
Form 4: Johnson Gillard B. Iii, Director
Granted 500,000 Stock Option |
| 04 Sep 2026 | 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year |
| 12 Aug 2026 | FORM 10-Q FOR JUN 2026 |
| 23 Jun 2026 | FORM 424(B)(3) |
| 18 Jun 2026 | EFFECT |
| 11 Jun 2026 | FORM S-1 |
| 11 Jun 2026 | FORM S-8 |
| 11 Jun 2026 | 8-K: Entry into a Material Definitive Agreement |
| 13 May 2026 | FORM 10-Q FOR MAR 2026 |
| 12 May 2026 | FORM AW |
| 30 Apr 2026 | FORM RW |
| 03 Apr 2026 |
Form 4: Staley Louis Jack Sr., Director
Received 5,000 shares as a grant or award |
| 03 Apr 2026 |
Form 4: Pennington Catherine B., Director
Received 5,000 shares as a grant or award |
| 03 Apr 2026 |
Form 4: Johnson Gillard B. Iii, Director
Received 5,000 shares as a grant or award |
| 13 Mar 2026 | POST-EFFECTIVE AMENDMENT 1 |
| 10 Mar 2026 | FORM 10-K FOR DEC 2025 |
| 13 Feb 2026 | EFFECT |
Loading...